CS32582
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CS32582, covering 2024-12-03 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis [Phase 1, Phase 2]